Uterine Fibroid Stocks List

Uterine Fibroid Stocks Recent News

Date Stock Title
Apr 25 NBIX Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data
Apr 25 ABBV Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Apr 25 ABBV AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Apr 25 ABBV AbbVie reports positive results from Rinvoq versus Dupixent study
Apr 25 ABBV AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1
Apr 25 ABBV UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Apr 25 ABBV Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Apr 25 ABBV New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
Apr 24 NBIX Neurocrine launches CAH community website ahead of FDA filing
Apr 24 ABBV AbbVie breaks six day winning cycle, trades in the red
Apr 24 ABBV Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
Apr 24 NBIX Neurocrine Biosciences upgraded at Wells Fargo on pipeline
Apr 24 ABBV 4 Large Drug Stocks to Hold on to Amid Industry Challenges
Apr 24 NBIX Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
Apr 24 ABBV What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Apr 24 NBIX Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community
Apr 24 ABBV Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Apr 23 ABBV Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s among 10 stocks set to surge
Apr 23 NBIX Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
Apr 23 NBIX No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
Uterine Fibroid

Uterine fibroids, also known as uterine leiomyomas or fibroids, are benign smooth muscle tumors of the uterus. Most women have no symptoms while others may have painful or heavy periods. If large enough, they may push on the bladder causing a frequent need to urinate. They may also cause pain during sex or lower back pain. A woman can have one uterine fibroid or many. Occasionally, fibroids may make it difficult to become pregnant, although this is uncommon.The exact cause of uterine fibroids is unclear. However, fibroids run in families and appear to be partly determined by hormone levels. Risk factors include obesity and eating red meat. Diagnosis can be performed by pelvic examination or medical imaging.Treatment is typically not needed if there are no symptoms. NSAIDs, such as ibuprofen, may help with pain and bleeding while paracetamol (acetaminophen) may help with pain. Iron supplements may be needed in those with heavy periods. Medications of the gonadotropin-releasing hormone agonist class may decrease the size of the fibroids but are expensive and associated with side effects. If greater symptoms are present, surgery to remove the fibroid or uterus may help. Uterine artery embolization may also help. Cancerous versions of fibroids are very rare and are known as leiomyosarcomas. They do not appear to develop from benign fibroids.About 20% to 80% of women develop fibroids by the age of 50. In 2013, it was estimated that 171 million women were affected worldwide. They are typically found during the middle and later reproductive years. After menopause, they usually decrease in size. In the United States, uterine fibroids are a common reason for surgical removal of the uterus.

Browse All Tags